MedTrace Logo

Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months

NCT00800488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2209

Last updated 2014-07-28

No results posted yet for this study

Summary

The primary objective is to study the value of serum procalcitonin as a predictive marker for severe bacterial infection in febrile infants.

2200 febrile infants aged less than 3 months will prospectively be included. All infants will have a measure of Procalcitonin concentrations. Comparison of the mean value of Procalcitonin concentration in infants with and without serious Bacterial infection.

Evaluation of the area under the ROC for Procalcitonin concentration.

Conditions

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Vincent GAJDOS, MD · Assistance Publique-Hôpitaux de Paris, Hôpital Antoine Béclère

Eligibility

Min Age
7 Days
Max Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-02-28
Completion
2011-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00800488 on ClinicalTrials.gov